Efficacy of CLR Compared to Fosfomycin Trometamol in Acute Lower uUTIs
NCT02639520
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
659
Enrollment
INDUSTRY
Sponsor class
Conditions
Urinary Tract Infection
Interventions
DRUG:
Canephron® N
DRUG:
Fosfomycin trometamol
DRUG:
Canephron® N-placebo
DRUG:
Fosfomycin trometamol-placebo
Sponsor
Bionorica SE